Catherine Arnst, senior writer for BusinessWeek
and
Carolina Hinestrosa, executive vice president of the National Breast Cancer Coaltion
- on the STAR study that found that Raloxifene could be used as much as Tamoxifen to prevent Breast Cancer
» "Lilly's Breast-cancer Breakthrough" by Catherine Arnst in Businessweek
» The National Breast Cancer Coalition
and
Carolina Hinestrosa, executive vice president of the National Breast Cancer Coaltion
- on the STAR study that found that Raloxifene could be used as much as Tamoxifen to prevent Breast Cancer
» "Lilly's Breast-cancer Breakthrough" by Catherine Arnst in Businessweek
» The National Breast Cancer Coalition
Leave a Comment
Register for your own account so you can vote on comments, save your favorites, and more. Learn more.
Please stay on topic, be civil, and be brief.
Email addresses are never displayed, but they are required to confirm your comments. Names are displayed with all comments. We reserve the right to edit any comments posted on this site. Please read the Comment Guidelines before posting. By leaving a comment, you agree to New York Public Radio's Privacy Policy and Terms Of Use.